|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1999-2-9
|
|
pubmed:abstractText |
Although increased mortality is one of the most consistent and accepted epidemiological findings in schizophrenia, a high rate of suicide appears unable to account fully for this burden which remains poorly understood.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0007-1250
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
173
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
325-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9926037-Adult,
pubmed-meshheading:9926037-Age Factors,
pubmed-meshheading:9926037-Aged,
pubmed-meshheading:9926037-Aged, 80 and over,
pubmed-meshheading:9926037-Antipsychotic Agents,
pubmed-meshheading:9926037-Cholinergic Antagonists,
pubmed-meshheading:9926037-Cohort Studies,
pubmed-meshheading:9926037-Female,
pubmed-meshheading:9926037-Humans,
pubmed-meshheading:9926037-Ireland,
pubmed-meshheading:9926037-Male,
pubmed-meshheading:9926037-Middle Aged,
pubmed-meshheading:9926037-Prospective Studies,
pubmed-meshheading:9926037-Schizophrenia,
pubmed-meshheading:9926037-Sex Factors,
pubmed-meshheading:9926037-Survival Analysis
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study.
|
|
pubmed:affiliation |
Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin. jwadding@rcsi.ie
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
